Kinesiophobia and Pressure Sore Risk After Bariatric Surgery.

November 27, 2025 updated by: Serafettin Okutan, Bitlis Eren University

Principal Investigator, Assistant Professor Şerafettin OKUTAN, Surgical Nursing, Faculty of Health Sciences, Bitlis Eren University

The aim of this study was to investigate the effect of emotional freedom technique on kinesiophobia and the risk of developing pressure sores in patients undergoing obesity surgery.

The hypotheses of the study are as follows:

H1-0: Emotional liberation technique has no effect on kinesiophobia in patients undergoing bariatric surgery.

H1-1: Emotional liberation technique has a positive effect on kinesiophobia in patients undergoing bariatric surgery.

H2-0: Emotional liberation technique has no effect on the risk of developing pressure ulcers in patients undergoing bariatric surgery.

H2-1: Emotional liberation technique has a positive effect on the risk of developing pressure ulcers in patients undergoing bariatric surgery.

Study Overview

Detailed Description

Intervention Group: After the pre-test application (Personal Introduction Form, Tampa Kinesiophobia Scale and Braden Pressure Sore Risk Assessment Scale) EFT was applied to the patients when they were stable before the bariatric surgery and they were taught to do it on their own. After the bariatric surgery, the patients were asked to do 1 session of EFT and were accompanied. After the application, the patients were applied post-tests (Tampa Kinesiophobia Scale and Braden Pressure Sore Risk Assessment Scale). EFT training was given by a researcher who has a certificate in the field.

Control Group Patients were administered pre-tests (Personal Introduction Form, Tampa Kinesiophobia Scale and Braden Pressure Sore Risk Assessment Scale) at a stable time before bariatric surgery. Post-tests (Tampa Kinesiophobia Scale and Braden Pressure Sore Risk Assessment Scale) were administered to patients after bariatric surgery at a stable time. After the post-tests, EFT was administered to patients in the control group.

Study Type

Interventional

Enrollment (Actual)

148

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Being 18 years of age or older
  2. Having had obesity surgery
  3. Not having any visual or auditory problems
  4. Not having any psychiatric problems.

Exclusion Criteria:

  1. Not accepting to participate in the study or wanting to leave
  2. Being under 18 years of age.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental: Intervention Group
After the pre-test application (Personal Introduction Form, Tampa Kinesiophobia Scale and Braden Pressure Sore Risk Assessment Scale) EFT was applied to the patients when they were stable before the bariatric surgery and they were taught to do it on their own. After the bariatric surgery, the patients were asked to do 1 session of EFT and were accompanied. After the application, the patients were applied post-tests (Tampa Kinesiophobia Scale and Braden Pressure Sore Risk Assessment Scale). EFT training was given by a researcher who has a certificate in the field.

Emotional Freedom Technique application; It is an application that works on cognitive and energetic levels.

Emotional Freedom Technique Application Instructions

  1. Determination of Subjective Units of Disturbance (SUD)
  2. Preparation or setup
  3. Application of appropriate acupuncture points in order
  4. 9-Gamut: An application that allows the two hemispheres of the brain to be stimulated simultaneously
  5. Application of appropriate acupuncture points in order again
  6. Control of the differentiation in the level of discomfort with SUDS again
No Intervention: No Intervention: Control Group
Pre-tests were administered to patients (Personal Introduction Form, Tampa Kinesiophobia Scale and Braden Pressure Sore Risk Assessment Scale) at a stable time before bariatric surgery. Post-tests (Tampa Kinesiophobia Scale and Braden Pressure Sore Risk Assessment Scale) were administered to patients (Tampa Kinesiophobia Scale and Braden Pressure Sore Risk Assessment Scale) at a stable time after bariatric surgery. After the post-tests, EFT was administered to patients in the control group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
kinesiophobia level
Time Frame: 20 minutes
It is a scale that measures movement restriction. As a result of the survey, the person receives a total score between 17-68 according to the answers they give. A high score on the scale indicates that the person has a high level of kinesiophobia. Those with a score above 37 are grouped as "high level kinesiophobia", those with a score of 37 and below are grouped as "low level kinesiophobia"
20 minutes
pressure ulcer risk
Time Frame: 20 minutes

The Braden Scale was developed in 1987 by Nancy Bergstrom, Barbara J. Braden and their colleagues for the early diagnosis of patients at risk of pressure ulcers.

The lowest score that can be obtained from the scale is 6, and the highest score is 23. Patients who receive 12 points or less from the scale are considered high risk, 13-14 points are considered risky, 15-16 points are considered low risk, and 15-18 points are considered low risk in patients over the age of 75

20 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Şerafettin OKUTAN, PhD., Bitlis Eren University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2025

Primary Completion (Actual)

September 25, 2025

Study Completion (Actual)

October 7, 2025

Study Registration Dates

First Submitted

January 13, 2025

First Submitted That Met QC Criteria

January 13, 2025

First Posted (Actual)

January 17, 2025

Study Record Updates

Last Update Posted (Estimated)

December 4, 2025

Last Update Submitted That Met QC Criteria

November 27, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Complementary Therapies

Clinical Trials on Emotional Freedom Technique

Subscribe